Literature DB >> 18661349

Versican in health and disease.

Achilleas D Theocharis1.   

Abstract

Versican is a component of the extracellular matrix, which interacts with several matrix and cell surface molecules. Versican plays central roles in tissue morphogenesis and homeostasis and is implicated in the development of numerous diseases. The expression of versican by multiple cell types is differentially regulated in a temporal and spatial manner in physiological and pathological processes. It participates in various biological events such as tissue organization, cell proliferation, adhesion, migration, and angiogenesis. The physiology of versican and its role in the progression of diseases such as atherosclerosis, cancer, and central nervous system injury are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661349     DOI: 10.1080/03008200802147571

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  25 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

2.  Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.

Authors:  Loren E Dupuis; Daniel R McCulloch; Jessica D McGarity; Alexandria Bahan; Andy Wessels; Deidra Weber; A Megan Diminich; Courtney M Nelson; Suneel S Apte; Christine B Kern
Journal:  Dev Biol       Date:  2011-07-01       Impact factor: 3.582

3.  Microarray comparison of the gene expression profiles in the adult vs. embryonic day 14 rat liver.

Authors:  Jie Zheng; Shuna Yu; Zhengchen Jiang; Caixing Shi; Jin Li; Xiaodong DU; Hailiang Wang; Jiying Jiang
Journal:  Biomed Rep       Date:  2014-06-25

Review 4.  Versican and the regulation of cell phenotype in disease.

Authors:  Thomas N Wight; Michael G Kinsella; Stephen P Evanko; Susan Potter-Perigo; Mervyn J Merrilees
Journal:  Biochim Biophys Acta       Date:  2014-01-05

Review 5.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

Review 6.  Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

Authors:  Achilleas D Theocharis; Chrisostomi Gialeli; Panagiotis Bouris; Efstathia Giannopoulou; Spyros S Skandalis; Alexios J Aletras; Renato V Iozzo; Nikos K Karamanos
Journal:  FEBS J       Date:  2014-11-06       Impact factor: 5.542

Review 7.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

8.  GORAB promotes embryonic lung maturation through antagonizing AKT phosphorylation, versican expression, and mesenchymal cell migration.

Authors:  Ying Liu; Xi Chen; Yeon Ja Choi; Ning Yang; Zhongya Song; Elizabeth R Snedecor; Wei Liang; Elaine Lai-Han Leung; Lianfeng Zhang; Chuan Qin; Jiang Chen
Journal:  FASEB J       Date:  2020-02-18       Impact factor: 5.191

9.  Genetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-type gastric cancer.

Authors:  Hyoungseok Ju; Byungho Lim; Minjin Kim; Seung-Moo Noh; Dong Soo Han; Hang-Jong Yu; Bo Youl Choi; Yong Sung Kim; Woo Ho Kim; Chunhwa Ihm; Changwon Kang
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-05       Impact factor: 4.553

Review 10.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.